![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1363912
¼¼°èÀÇ ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå(2023-2030³â)Global Surgical Sutures Market 2023-2030 |
¼¼°è ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È CAGR 5.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ»ç´Â ºÀÇջ縦 »ç¿ëÇÏ¿© »óó¿Í Âõ¾îÁüÀ» Ä¡·áÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛ ¹× ½ÃÆ®¸®Á¨TM°ú °°Àº ±â¼úÀû Áøº¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛÀº Á¤Çü¿Ü°ú ¹× ¿¬ºÎÁ¶Á÷ ½Ã¼ú¿¡ »ç¿ëµÇ¸ç, ƯÈ÷ ¿¬ºÎÁ¶Á÷°ú »À »çÀÌÀÇ °ß°íÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °áÇÕÀÌ ÇÊ¿äÇÑ °æ¿ì¿¡ »ç¿ëµË´Ï´Ù. ±âÁ¸ ±â¼ú·Î ¿¬Á¶Á÷À» »À¿¡ ºÎÂøÇÏ¸é ºÀÇջ簡 ºüÁö°Å³ª ½ÇÆÐÇÏ´Â µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó °¢ ±â¾÷µéÀº ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛ ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ ½ÅÁ¦Ç°À» Ãâ½ÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 12¿ù, ½ºÆ®¶óÀÌÄ¿´Â Á·°üÀý ¼ö¼ú¿ë ºÀÇÕ»ç ¾ÞÄ¿ ½Ã½ºÅÛ Citrefix(TM)¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ½Å±â¼úÀº õ¿¬ »ÀÀÇ ±¸¼º°ú ±¸Á¶¸¦ ¸ð¹æÇØ ¸¸µç »ýü Èí¼ö¼º ¹°ÁúÀÎ ½ÃÆ®·¹°Õ(CitregenTM)À» Ȱ¿ëÇÑ °ÍÀ¸·Î, ÀÏȸ¿ë ºÀÇջ縦 À§ÇÑ »ýü Èí¼ö¼º ºÀÇÕ»ç ¾ÞÄ¿¸µ ½Ã½ºÅÛÀÔ´Ï´Ù.
Á¦Ç° À¯Çü Áß Èí¼ö¼º ÇÏÀ§ ºÎ¹®Àº ¼¼°è ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀº ºÀÇÕ»ç Á¦°ÅÀÇ Çʿ伺À» ÁÙÀ̱â À§ÇÑ ¼ö¿ä Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. Èí¼ö¼º ºÀÇÕ»ç´Â ¿ëÇØ¼º ºÀÇÕ»ç¶ó°íµµ ÇÕ´Ï´Ù. Èí¼ö¼º ºÀÇջ翡´Â ¿©·¯ °¡Áö ÀåÁ¡ÀÌ Àִµ¥, ±× Áß Çϳª´Â »óó°¡ Ä¡À¯µÈ ÈÄ ºÀÇջ縦 Á¦°ÅÇÒ Çʿ䰡 ¾ø¾î ½Ã°£À» Àý¾àÇϰí ȯÀÚÀÇ °íÅëÀ» ÃÖ¼ÒÈÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ƯÈ÷ ½ÉºÎ Á¶Á÷ Æó¼â ¹× ³»ºÎ ½Ã¼ú¿¡ ÀûÇÕÇÕ´Ï´Ù. Èí¼ö¼º ºÀÇÕ»ç´Â µ¿¹°ÀÇ ÀåÀ» µ¤°í ÀÖ´Â ¼¶À¯³ª ÇÕ¼º °íºÐÀÚ µî ü³»¿¡¼ ½±°Ô ¿ëÇØµÇ´Â ¹°Áú·Î ¸¸µé¾îÁý´Ï´Ù. Èí¼ö¼º ºÀÇÕ»ç´Â ½ÇÅ© ºÀÇջ糪 ³ªÀÏ·Ð ºÀÇÕ»çó·³ Àü¹®ÀûÀÎ ¹Ú¸®¿¡ ÀÇÁ¸ÇÏÁö ¾Ê½À´Ï´Ù. µû¶ó¼ ¿Ü°ú Àû Àý°³ ¹× ³»ºÎ »óó Ä¡À¯¿¡ È¿°úÀûÀÔ´Ï´Ù.
¼¼°è ¼ö¼ú¿ë ºÀÇÕ»ç ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù), À¯·´(¿µ±¹, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, µ¶ÀÏ, ÇÁ¶û½º, ±âŸ À¯·´), ¾Æ½Ã¾ÆÅÂÆò¾ç(Àεµ, Áß±¹, ÀϺ», Çѱ¹, ±âŸ ¾Æ½Ã¾Æ Áö¿ª), ±âŸ Áö¿ª(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, ¶óƾ¾Æ¸Þ¸®Ä«) µî Áö¿ªº°·Î ¼¼ºÐȵ˴ϴÙ. ¼¼ºÐȵǾî ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì´Â Ç×±Õ ÄÚÆÃµÈ »ýüÀûÇÕ¼º ¼ö¼ú¿ë ºÀÇÕ»ç µî Çõ½ÅÀûÀÎ ¼ö¼ú ±â¹ý ¹× Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ¼¼°è ½ÃÀå¿¡¼ µÎµå·¯Áø Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸ðµç Áö¿ª Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ´Â ¼ö¼ú¿ë ºÀÇÕ»ç ¼ö¿ä Áõ°¡´Â ³ëÀÎ Àα¸ÀÇ Áúº´ ¹ß»ý·ü Áõ°¡¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °ü»óµ¿¸Æ ¿ìȸ¼ú, ´ëµ¿¸Æ ¹× ½Â¸ðÆÇ¸· ±³Ã¼ ¹× ¼ö¸®, µ¿¸Æ·ù ¼ö¼úÀº ÀϹÝÀûÀÎ ½ÉÇ÷°ü ¼ö¼úÀÔ´Ï´Ù. ¼ö¼úÀÇ Áß¿äÇÑ ¿ä¼Ò´Â ºÀÇÕÀÔ´Ï´Ù. ½ºÅ×Àη¹½º ½ºÆ¿, Æú¸®ÇÁ·ÎÇÊ·», Æú¸®¿¡½ºÅ׸£ ºÀÇÕ»ç´Â ½ÉÀå ºÀÇջ翡 »ç¿ëµÇ´Â Àç·á Áß ÇϳªÀÔ´Ï´Ù.2020³â 1¿ù Àεµ °¡Á·º¸°Çº¹ÁöºÎ°¡ ¹ßÇ¥ÇÑ Á¦1Â÷ ÀεµÁ¾´Ü³ë·ÉÈÁ¶»ç(LASI)¿¡ µû¸£¸é Àεµ¿¡¼´Â ³ëÀÎ 3¸í Áß 1¸íÀÌ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. Àεµ¿¡¼´Â °ÅÀÇ 70%ÀÇ ³ëÀÎÀÌ ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. Á¶»ç¿¡ µû¸£¸é, °í·ÉÀÚ(60¼¼ ÀÌ»ó)ÀÇ ¾à 23%°¡ ´Ù¹ß¼º ÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç, °í·É ¿©¼ºÀϼö·Ï ÀÌ·¯ÇÑ °æÇâÀÌ ´õ °ÇÕ´Ï´Ù. Á¶»ç °á°ú¿¡´Â ½ÃÅ´À» Á¦¿ÜÇÑ ¸ðµç ÁÖ¿Í ¿¬¹æ Á÷ÇÒ·ÉÀÇ ³ëÀÎ 72,000¸í ÀÌ»ó¿¡ ÇØ´çÇÏ´Â 42,000¿© °¡±¸ÀÇ Á¤º¸°¡ Æ÷ÇԵŠÀÖ½À´Ï´Ù.
Á¦1Â÷ ÀεµÁ¾´Ü³ë·ÉÈÁ¶»ç(LASI)¿¡ µû¸£¸é, 45¼¼ ÀÌ»ó Àα¸°¡ ÀÚ°¡º¸°íÇÑ ½É°¢ÇÑ ¸¸¼ºÁúȯ°ú ´Ù¹ß¼º ÁúȯÀÇ ¼ö°¡ ¿¬·ÉÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Áõ°¡ÇÏ¿´½À´Ï´Ù. ½ÉÇ÷°ü Áúȯ(CVD)°ú °íÇ÷¾ÐÀº 75¼¼ À̻󿡼 µÎµå·¯Áø ¸¸¼º ÁúȯÀÔ´Ï´Ù. ³ªÀ̰¡ µé¾î°¨¿¡ µû¶ó ¹«ÁúȯÀÚÀÇ ºñÀ²Àº Áö¼ÓÀûÀ¸·Î °¨¼ÒÇϰí ÀÖÀ¸¸ç, 45¼¼ ÀÌÇÏ¿¡¼´Â 73%°¡ ¹«ÁúȯÀÚ·Î ÃßÁ¤µÇÁö¸¸ 75¼¼ À̻󿡼´Â ÀÌ ºñÀ²ÀÌ 44%±îÁö °¨¼ÒÇÕ´Ï´Ù. ÇÏÁö¸¸ 60¼¼ À̻󿡼´Â ±× °¨¼ÒÆøÀÌ ¿Ï¸¸ÇØÁý´Ï´Ù.
Title: Global Surgical Sutures Market Size, Share & Trends Analysis Report by Product Type (Absorbable Sutures, and Non-absorbable Sutures), by Application (Ophthalmic Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurology Surgery, and Others), and by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Clinics and Physician Offices)Forecast Period (2023-2030).
The global surgical sutures market is anticipated to grow at a CAGR of 5.8% during the forecast period (2023-2030). Doctors use sutures to treat wounds and lacerations. The market's growth is attributed to growing demand for technological advancements such as suture anchor system, and citregenTM. Suture anchor systems are employed during orthopedic and soft tissue procedures, especially when a secure and reliable bond amongst the soft tissue and the bone is required. Complications such as suture pull-through or failure can occur when attaching soft tissues to bone using the conventional technique. Accordingly market players are coming up with new products to cater the demand for suture anchor system. For instance, in December 2022, Stryker launched a Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new technology involves the utilization of CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for disposable sutures.
The global surgical sutures market is segmented on the product type, application, and end user. Based on the product type, the market is sub-segmented into absorbable sutures (natural sutures, synthetic sutures), and non-absorbable sutures (nylon, prolene, and others). Based on the application, the market is sub-segmented into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurology surgery, and others. Further, on the basis of end-user, the market is sub-segmented into hospitals and clinics, ambulatory surgical centers, and clinics and physician offices. Among the application, the orthopedic surgery sub-segment is anticipated to hold a considerable share of the market owing to the numbers of orthopedic conditions influencing the senior citizen population and growing numbers of individuals seeking orthopedic surgery globally. For instance, according to National Institute of Health, globally, the incidence of arthritis was 203 per 10,000 individuals.
Among the product type, the absorbable sub-segment is expected to hold a significant share of the global surgical sutures market. The segmental growth is attributed to growing demand for reduced need for suture removal. Absorbable sutures, additionally known as dissolvable sutures. Absorbable sutures offer a variety of benefits such as, one of that is the fact that they don't need to be removed once the wound has healed, saving time and minimizing patient suffering. This quality makes them especially well-suited for deep tissue closures and interior procedures. They originate from substances that easily dissolve in the body, such as fibers that line the intestines of animals or synthetic polymers. Absorbable sutures are not dependent on professional removals such as silk or nylon sutures. They are therefore effective for healing surgical incisions and interior wounds.
The global surgical sutures market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the increase in demand for innovative surgical techniques and equipment, such as biocompatible surgical sutures with antimicrobial coatings.
Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. The increasing demand for surgical sutures, that is subsequently fueling the region's growth, is projected to result from the disease's increased incidence among the older population. Coronary bypass surgery, aortic or mitral valve replacement or repair, and aneurysm repair are common cardiovascular procedures. A significant component of surgery is suturing. Stainless steel, polypropylene, and polyester sutures are among the materials utilized for cardiac sutures. According to the First Longitudinal Ageing Study in India (LASI), that was published by the Union Ministry of Family and Health Welfare in January 2020, both out of every three elderly individuals in India have a chronic illness. Almost 70% senior citizens in India have a chronic illness. According to the research, multi-morbidity conditions affect about 23% of senior citizens (60 years and older); older women are more likely to have such disorders. The survey's findings included information from more than 42,000 homes, representing more than 72,000 senior citizens in all states and union territories with the exception of Sikkim.
According to the First Longitudinal Ageing Study in India (LASI), the number of significant chronic health disorders and multi-morbidities that people over the age of 45 self-reported having increased with age. Cardiovascular diseases (CVD) and hypertension predominate among the chronic health disorders that are prominent among individuals 75 years of age and older. As individuals aged, the proportion of those without morbidity continually fell. It is estimated that 73% of people under the age of 45 are free of morbid conditions, and this percentage drops to 44% among individuals 75 and older. From the age of 60 onward, the decline is, nevertheless, slower.
The major companies serving the surgical sutures market include B.Braun SE, Coloplast Corp., DemeTECH Corp., Dolphin Sutures, Kono Seisakusho Co., Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in in April 2021, Dolphin Sutures, launched a non-absorbable polytetrafluoroethylene (PTFE) suture. PTFE is very strong, knots well, and is biologically inert.